Gene and protein expression in experimental ... - Wiley Online Library

3 downloads 1447 Views 140KB Size Report
Gene ID Converter (http://idconverter.bioinfo.cnio.es). Each gene list was ... genome.jp/kegg/pathway.html) are presented. As summa- rized in Table 1 and Fig. ... (2004) Nxf and Fbxo33: novel seizure-responsive genes in mice. Eur J Neurosci.
Epilepsia, 48(Suppl. 8):28–32, 2007 doi: 10.1111/j.1528-1167.2007.01342.x

MOLECULAR NATURE OF STATUS EPILEPTICUS

Gene and protein expression in experimental status epilepticus ∗

Katarzyna Lukasiuk and †‡Asla Pitk¨anen

∗ The Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland; †A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland; and ‡Department of Neurology, Kuopio University Hospital, Kuopio, Finland

Epilepsies are the second most common neurologic disorder after stroke (Porter, 1993). It is estimated that approximately 0.8% of the population is affected by some form of epilepsy. In approximately 30% of cases, epilepsy is a re-

sult of an insult to the brain, such as traumatic brain injury (TBI), stroke, brain infection, prolonged complex febrile seizures, or status epilepticus (SE) (Hauser, 1997). In such cases, the initial insult is commonly followed by a latency period (epileptogenesis) that can last for months or years before the appearance of spontaneous seizures and epilepsy diagnosis (Pitkanen and Sutula, 2002). Changes in gene expression leading to network reorganization and neuronal hyperexcitability are crucial to understanding epilepsy and have been extensively studied.

Address correspondence and reprint requests to Prof. Asla Pitk¨anen, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, PO Box 1627, FIN-70 211 Kuopio, Finland. E-mail: [email protected] Blackwell Publishing, Inc.  C International League Against Epilepsy

Table 1. Cellular and metabolic processes pathways (according to KEGG) detected in various datasets containing lists of genes changing the level of expression 1 day following status epilepticus Elliott et al. (2003) ALS Antigen processing and presentation Apoptosis Axon guidance Basal transcription factors Calcium signaling Cell adhesion molecules Cell communication Cell cycle Complement and coagulation cascade Cytokine-cytokine receptor interaction ECM receptor interaction FC epsilon RI signaling Focal adhesion Gap junction Hematopoietic cell lineage Huntington’s disease Insulin signaling JAK-stat signaling Leukocyte transendothelial migration LTP MAPK signaling Natural killer-mediated cytotoxicity Neuroactive ligand-receptor interaction Neurodegenerative disorders Phospatidiloinositol signaling Regulation of actin cytoskeleton Ribosome TGF-beta signaling Tight junction Type I diabetes mellitus Wnt signaling

Hunsberger et al. (2005)

Lukasiuk et al. (2003)

Tang et al. (2002)

x x

x x x x x x x x x

x x

x x

x

x x x x x

x

x

x x

x x

x x

x x x x x x

x

x x

x x

x x x x

x x x

x x

x x x x

x

x x

28

x

29 Experimental Status Epilepticus

Figure 1. Selected cellular and metabolic processes pathways interactions detected in datasets containing lists of genes changing the level of expression 1 day following status epilepticus. Each graph presents the network of associations between protein products of genes provided by each gene list, which was found in KEGG pathway database. Nodes of the networks represent proteins and lines connecting nodes represent interactions between proteins. The thickness of lines codes for number of cellular pathways in which given connection has been described. The nodes and lines indicated in dark gray represent the pathway named in column heading. C ILAE Epilepsia  Epilepsia, 48(Suppl. 8):28–32, 2007 doi: 10.1111/j.1528-1167.2007.01342.x

30 K. Lukasiuk and A. Pitk¨anen

Figure 1. Continued. C ILAE Epilepsia 

Epilepsia, 48(Suppl. 8):28–32, 2007 doi: 10.1111/j.1528-1167.2007.01342.x

31 Experimental Status Epilepticus The application of recent technologic developments that allow the analysis on the level of whole genom or proteom supported by novel bioinformatic tools provides an unbiased insight into molecular events that occur in the brain. Global analysis of gene expression has been successfully employed to decipher molecular response of the brain to seizures (Sandberg et al., 2000; French et al., 2001; Newton et al., 2003; Flood et al., 2004; Li X et al., 2005), status epilepticus (Nedivi et al., 1993; Hevroni et al., 1998; Hendriksen et al., 2001; Liang and Seyfried, 2001; Tang et al., 2002; Becker et al., 2003; Elliott et al., 2003; Lukasiuk et al., 2003; Hunsberger et al., 2005; Wilson et al., 2005; Gorter et al., 2006), kindling (Liang and Seyfried, 2001; Potschka et al., 2002; Arai et al., 2003; Gu et al., 2004), as well as alterations in pattern of gene expression in both experimental (Bo et al., 2002; Arai et al., 2003) and human (Crino et al., 2001; Becker et al., 2002; Kim et al., 2003; Rakhade et al., 2005; Arion et al., 2006; Jamali et al., 2006; Ozbas-Gerceker et al., 2006) epilepsy. Each of above works leads to detection of changes in expression of up to hundreds of genes that supposedly are of importance for epilepsy. Data on global analyses of gene expression lead not only to the identification of new epilepsy-related genes but also to formulation of several hypotheses implying role in epilepsy for particular processes or metabolic pathways. For example, the potential role for electrical activity (Arion et al., 2006), angiogenesis (Newton et al., 2003), neurotrophic factors (Newton et al., 2003), immune response (Gorter et al., 2006; Lukasiuk et al., 2006), or events recapitulating development (Elliott et al., 2003) has been suggested. A number of studies concentrated on immediate and delayed consequences of SE on gene expression. In-depth analysis of already existing data aiming at pinpointing most prominent metabolic pathways affected could lead to identification of most important players in the SEinduced sequel and hopefully will help to find targets for future treatments. We had successfully applied such strategy in our recent metaanalysis of available data on epileptogenesis-related alterations of gene expression. In above analysis, we have detected over- and under-representation of number of functional groups of genes, so called GO-terms (gene ontology terms defined by the Gene Ontology Consortium, http://www.geneontology.org/) across different experimental models of epileptogenesis (Lukasiuk et al., 2006). Over-represented GO terms include, for example, immune response genes. Crucial role of immune response genes has been corroborated recently by new data on transcriptome response following electrically induced SE (Gorter et al., 2006). Here, we employed similar approach, but this time we were looking not for GOterms, but for functional pathways which are represented by genes detected as changing expression level following SE. To do this, we have used published lists of genes that change expression level 1 day after pilocarpine (El-

liott et al., 2003), kainic acid (Tang et al., 2002; Hunsberger et al., 2005), or electrical stimulation-induced SE (Lukasiuk et al., 2003). Gene list were used as published by the authors if GenBank accession numbers were provided with the list. If gene list contained only gene names, the GenBank accession numbers were imputed using Clone/ Gene ID Converter (http://idconverter.bioinfo.cnio.es). Each gene list was analyzed with Pathway Miner (BioRag – Bio Resource for Array Genes at http://www.biorag.org) that classifies and extracts network of associated genes based on pathways. Only pathways defined by KEGG (Kyoto Encyclopedia of Genes and Genomes, http://www. genome.jp/kegg/pathway.html) are presented. As summarized in Table 1 and Fig. 1, genes changing expression level following SE represent several cellular pathways and number of these pathways are represented across different experimental models. Such commonly found interactions belong to pathways involved in MAPK kinase signaling, regulation of actin cytoskeleton, leukocyte transendothelial migration, calcium signaling, or cell cycle. Further research is required to explain the meaning of these data in context of SE-induced alterations in brain function.

R EFERENCES Arai M, Amano S, Ryo A, Hada A, Wakatsuki T, Shuda M, Kondoh N, Yamamoto M. (2003) Identification of epilepsy-related genes by gene expression profiling in the hippocampus of genetically epileptic rat. Brain Res Mol Brain Res 118(1–2):147–151. Arion D, Sabatini M, Unger T, Pastor J, Alonso-Nanclares L, BallesterosYanez I, Garcia Sola R, Munoz A, Mimics K, Defelipe J. (2006) Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy. Neurobiol Dis 22(2):374–387. Becker AJ, Chen J, Paus S, Normann S, Beck H, Elger CE, Wiestler OD, Bl¨umcke I. (2002) Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation. Neuroreport 13(10):1327–1333. Becker AJ, Chen J, Zien A, Sochivko D, Normann S, Schramm J, Elger CE, Wiestler OD, Bl¨umcke I. (2003) Correlated stage- and subfieldassociated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur J Neurosci 18(10):2792–2802. Bo X, Zhiguo W, Xiaosu Y, Guoliang L, Guangjie X. (2002) Analysis of gene expression in genetic epilepsy-prone rat using a cDNA expression array. Seizure 11(7):418–422. Crino PB, Duhaime AC, Baltuch G, White R. (2001) Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 56(7):906–913. Elliott RC, Miles MF, Lowenstein DH. (2003) Overlapping microarray profiles of dentate gyrus gene expression during developmentand epilepsy-associated neurogenesis and axon outgrowth. J Neurosci 23(6):2218–2227. Flood WD, Moyer RW, Tsykin A, Sutherland GR, Koblar SA. (2004) Nxf and Fbxo33: novel seizure-responsive genes in mice. Eur J Neurosci 20(7):1819–1826. French PJ, O’Connor V, Voss K, Stean T, Hunt SP, Bliss TV. (2001) Seizure-induced gene expression in area CA1 of the mouse hippocampus. Eur J Neurosci 14(12):2037–2041. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, et al. (2006) Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26(43):11083–11110. Gu J, Lynch BA, Anderson D, Klitgaard H, Lu S, Elashoff M, et al. (2004) The antiepileptic drug levetiracetam selectively modifies Epilepsia, 48(Suppl. 8):28–32, 2007 doi: 10.1111/j.1528-1167.2007.01342.x

32 K. Lukasiuk and A. Pitk¨anen kindling-induced alterations in gene expression in the temporal lobe of rats. Eur J Neurosci (2):334–345. Hauser WA. (1997) Incindence and prevalence. In Engel JJ, Pedley TA. (Eds) Epilepsy: a comprehensive textbook. Lippincott-Raven Publishers, Philadelphia, pp. 47–57. Hendriksen H, Datson NA, Ghijsen WE, van Vliet EA, da Silva FH, Gorter JA, Vreugdenhil E. (2001) Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur J Neurosci 14(9):1475–1484. Hevroni D, Rattner A, Bundman M, Lederfein D, Gabarah A, Mangelus M, Silverman MA, Kedar H, Naor C, Kornuc M, Hanoch T, Seger R, Theill LE, Nedivi E, Richter-Levin G, Citri Y. (1998) Hippocampal plasticity involves extensive gene induction and multiple cellular mechanisms. J Mol Neurosci 10(2):75–98. Hunsberger JG, Bennett AH, Selvanayagam E, Duman RS, Newton SS. (2005) Gene profiling the response to kainic acid induced seizures. Brain Res Mol Brain Res 141(1):95–112. Jamali S, Bartolomei F, Robaglia-Schlupp A, Massacrier A, Peragut JC, Regis J, Dufour H, Ravid R, Roll P, Pereira S, Royer B, RoeckelTrevisiol N, Fontaine M, Guye M, Boucraut J, Chauvel P, Cau P, Szepetowski P. (2006) Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129(Pt 3):625–641. Kim SK, Wang KC, Hong SJ, Chung CK, Lim SY, Kim YY, Chi JE, Kim CJ, Chung YN, Kim HJ, Cho BK. (2003) Gene expression profile analyses of cortical dysplasia by cDNA arrays. Epilepsy Res 56(2– 3):175–183. Li X, Yang Q, Hu Y. (2005) Gene expression profiling reveals the mechanism of action of anticonvulsant drug QYS. Brain Res Bull 66(2):99– 105. Liang D, Seyfried TN. (2001) Genes differentially expressed in the kindled mouse brain. Brain Res Mol Brain Res 96(1–2):94–102. Lukasiuk K, Kontula L, Pitkanen A. (2003) cDNA profiling of epileptogenesis in the rat brain. Eur J Neurosci 17(2):271–279. Lukasiuk K, Dabrowski M, Adach A, Pitkanen A. (2006) Epileptogenesis-related genes revisited. Prog Brain Res 158:223–241.

Epilepsia, 48(Suppl. 8):28–32, 2007 doi: 10.1111/j.1528-1167.2007.01342.x

Nedivi E, Hevroni D, Naot D, Israeli D, Citri Y. (1993) Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 363(6431):718–722. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, Duman RS. (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23(34):10841–10851. Ozbas-Gerceker F, Redeker S, Boer K, Ozguc M, Saygi S, Dalkara T, Soylemezoglu F, Akalan N, Baayen JC, Gorter JA, Aronica E. (2006) Serial analysis of gene expression in the hippocampus of patients with mesial temporal lobe epilepsy. Neuroscience 138(2):457–474. Pitkanen A, Sutula TP. (2002) Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 1(3):173–181. Porter RJ. (1993) Classification of epileptic seizures and epileptic syndromes. In Laidlaw J, Richens A, Chadwick D (Eds) A textbook of epilepsy. Churchill Livingstone, Edinburgh, pp. 1–22. Potschka H, Krupp E, Ebert U, Gumbel C, Leichtlein C, Lorch B, Pickert A, Kramps S, Young K, Gr¨une U, Keller A, Welschof M, Vogt G, Xiao B, Worley PF, L¨oscher W, Hiemisch H. (2002) Kindling-induced overexpression of Homer 1A and its functional implications for epileptogenesis. Eur J Neurosci 16(11):2157–2165. Rakhade SN, Yao B, Ahmed S, Asano E, Beaumont TL, Shah AK, Draghici S, Krauss R, Chugani HT, Sood S, Loeb JA. (2005) A common pattern of persistent gene activation in human neocortical epileptic foci. Ann Neurol 58(5):736–747. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C. (2000) Regional and strainspecific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 97(20):11038–11043. Tang Y, Lu A, Aronow BJ, Wagner KR, Sharp FR. (2002) Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 15(12):1937–1952. Wilson DN, Chung H, Elliott RC, Bremer E, George D, Koh S. (2005) Microarray analysis of postictal transcriptional regulation of neuropeptides. J Mol Neurosci 25(3):285–298.